Authors: GREENWALD MK STITZER ML HABERNY KA

Citation: Mk. Greenwald et al., HUMAN PHARMACOLOGY OF THE OPIOID NEUROPEPTIDE DYNORPHIN A(1-13), The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1154-1163

Authors: HABERNY KA WALSH SL GINN DH WILKINS JN GARNER JE SETODA D BIGELOW GE

Citation: Ka. Haberny et al., ABSENCE OF ACUTE COCAINE INTERACTIONS WITH THE MAO-B INHIBITOR SELEGILINE, Drug and alcohol dependence, 39(1), 1995, pp. 55-62

Authors: HABERNY KA YOUNG GA

Citation: Ka. Haberny et Ga. Young, ACUTE INTERACTIVE EFFECTS OF MK-801 AND MORPHINE ON CORTICAL EEG AND EEG POWER SPECTRA IN RATS, Brain research bulletin, 36(4), 1995, pp. 325-331

Authors: HABERNY KA YOUNG GA

Citation: Ka. Haberny et Ga. Young, INTERACTIVE EFFECTS OF MK-801 AND MORPHINE ON EEG, EEG POWER SPECTRA AND BEHAVIOR IN RATS .1. MORPHINE-TOLERANCE DEVELOPMENT, European journal of pharmacology, 261(1-2), 1994, pp. 1-9

Authors: HABERNY KA YOUNG GA

Citation: Ka. Haberny et Ga. Young, INTERACTIVE EFFECTS OF MK-801 AND MORPHINE ON EEG, EEG POWER SPECTRA AND BEHAVIOR IN RATS .2. MORPHINE-DEPENDENCE, European journal of pharmacology, 261(1-2), 1994, pp. 11-16